Skip to main content
PFE
NYSE Life Sciences

Pfizer's Acquired Obesity Drug PF-3944 Shows 12.3% Weight Loss, Targets 2028 Approval

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$25.719
Mkt Cap
$146.476B
52W Low
$23.11
52W High
$28.745
52W Position info
11% above low
Off High info
11% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.11 (11% above the low).

Summary

Pfizer's obesity drug candidate, PF-3944, acquired through the Metsera buyout, demonstrated up to 12.3% mean weight loss at 28 weeks with monthly injections. This follows the previously announced acquisition of Metsera's obesity assets on April 1st. The strong efficacy data for PF-3944 positions it as a competitive asset in the rapidly growing obesity market, adding significant potential to Pfizer's pipeline. The company is targeting first approval for PF-3944 by 2028.

At the time of this announcement, PFE was trading at $25.72 on NYSE in the Life Sciences sector, with a market capitalization of approximately $146.5B. The 52-week trading range was $23.11 to $28.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $29.90 info
Change: -$0.7594 (-2%) info
Market Cap: $170.312B info
PFE
Nov 03, 2026, 8:07 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.62
Real-time Price: $29.90 info
Change: -$0.7248 (-2%) info
Market Cap: $170.312B info
PFE
Nov 03, 2026, 6:55 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $30.73
Real-time Price: $29.90 info
Change: -$0.830 (-3%) info
Market Cap: $170.312B info
PFE
Nov 03, 2026, 6:45 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $30.98
Real-time Price: $29.90 info
Change: -$1.08 (-3%) info
Market Cap: $170.312B info
PFE
Oct 27, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.77
Real-time Price: $29.90 info
Change: +$0.130 (+0.44%) info
Market Cap: $170.312B info